We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$9.03B
AUM Growth
-$1.37B
Cap. Flow
-$1.22B
Cap. Flow %
-13.56%
Top 10 Hldgs %
18.31%
Holding
2,015
New
576
Increased
314
Reduced
307
Closed
636

Top Buys

Rank Stock Value
1
SKX
Skechers
SKX
+$18.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$17.4M
3
INSM icon
Insmed
INSM
+$16.1M
4
GILD icon
Gilead Sciences
GILD
+$15.8M
5
K
Kellanova
K
+$15.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.58%
2 Healthcare 3.09%
3 Consumer Discretionary 2.5%
4 Technology 1.62%
5 Financials 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRNX
1076
CALL
DELISTED
Crinetics Pharmaceuticals
CRNX
$575K 0.01%
+20,000
New +$618K
FIP icon
1077
CALL
FTAI Infrastructure
FIP
$332M
$575K 0.01%
+93,200
New +$472K
BRZE icon
1078
Braze
BRZE
$2.82B
$573K 0.01%
+20,380
New +$644K
KBH icon
1079
KB Home
KBH
$2.98B
$569K 0.01%
+10,750
New +$572K
FISV
1080
Fiserv Inc
FISV
$26.2B
$569K 0.01%
+3,300
New +$598K
AGIO icon
1081
Agios Pharmaceuticals
AGIO
$2.01B
$565K 0.01%
17,000
-53,000
-76% -$1.61M
VRNS icon
1082
Varonis Systems
VRNS
$5.47B
$563K 0.01%
+11,100
New +$505K
UUUU icon
1083
Energy Fuels
UUUU
$3.2B
$563K 0.01%
97,945
-112,055
-53% -$538K
SRAD icon
1084
Sportradar
SRAD
$3.69B
$562K 0.01%
+20,000
New +$475K
VRDN icon
1085
CALL
Viridian Therapeutics
VRDN
$2.47B
$559K 0.01%
40,000
+7,300
+22% +$99.1K
ARWR icon
1086
Arrowhead Research
ARWR
$9.56B
$553K 0.01%
35,000
+17,900
+105% +$257K
FHN icon
1087
CALL
First Horizon
FHN
$11.4B
$551K 0.01%
26,000
-22,000
-46% -$419K
FANG icon
1088
Diamondback Energy
FANG
$54.9B
$550K 0.01%
4,000
-80
-2% -$11.1K
EW icon
1089
Edwards Lifesciences
EW
$50.9B
$548K 0.01%
+7,012
New +$523K
MRK icon
1090
Merck
MRK
$363B
$546K 0.01%
+6,900
New +$548K
OTIS icon
1091
Otis Worldwide
OTIS
$26.1B
$545K 0.01%
+5,500
New +$531K
NAMS icon
1092
PUT
NewAmsterdam Pharma
NAMS
$2.59B
$543K 0.01%
+30,000
New +$547K
GPRE icon
1093
Green Plains
GPRE
$1.07B
$541K 0.01%
89,682
+32,182
+56% +$142K
JHX icon
1094
James Hardie Industries
JHX
$15.2B
$538K 0.01%
+20,000
New +$483K
WHD icon
1095
CALL
Cactus
WHD
$4.72B
$538K 0.01%
12,300
ETSY icon
1096
Etsy
ETSY
$6.66B
$537K 0.01%
10,700
-5,300
-33% -$264K
AOUT icon
1097
American Outdoor Brands
AOUT
$201M
$536K 0.01%
51,280
-43,903
-46% -$502K
MREO
1098
Mereo BioPharma
MREO
$46.2M
$535K 0.01%
197,599
+92,816
+89% +$224K
DOCN icon
1099
DigitalOcean
DOCN
$15.7B
$527K 0.01%
18,463
-171,096
-90% -$5M
FLYW icon
1100
CALL
Flywire
FLYW
$2.17B
$527K 0.01%
45,000

Similar funds

Caption Management's Q2 2025 Portfolio in Review

As of Q2 2025, Caption Management held 2,015 positions worth $9.03B, down 13% from $10.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management withdrew a net $1.22B in Q2 2025, closing 636 positions and reducing 307 holdings. Its most notable exit was Microsoft, an estimated $394M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 79% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Caption Management opened a new position in Skechers worth $20.1M.

  • Caption Management's largest Q2 2025 buy was Skechers: 317,932 shares worth $20.1M.
  • Caption Management added most to Kellanova in Q2 2025, an estimated $15.3M increase.
  • Caption Management's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $121M.
  • Caption Management fully exited Microsoft in Q2 2025, selling an estimated $394M.
  • Caption Management's ten largest holdings make up 18% of its $9.03B portfolio in Q2 2025.
  • Caption Management opened 576 new positions and closed 636 in Q2 2025.
  • Caption Management's portfolio value fell 13% quarter-over-quarter to $9.03B.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.